2021
DOI: 10.1016/j.isci.2021.103323
|View full text |Cite
|
Sign up to set email alerts
|

Genome-wide CRISPR-Cas9 screens identify mechanisms of BET bromodomain inhibitor sensitivity

Abstract: Summary BET bromodomain inhibitors hold promise as therapeutic agents in diverse indications, but their clinical progression has been challenging and none have received regulatory approval. Early clinical trials in cancer have shown heterogeneous clinical responses, development of resistance, and adverse events. Increased understanding of their mechanism(s) of action and identification of biomarkers are needed to identify appropriate indication(s) and achieve efficacious dosing. Using genome-wide CR… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
11
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
3
2

Relationship

2
3

Authors

Journals

citations
Cited by 8 publications
(11 citation statements)
references
References 88 publications
0
11
0
Order By: Relevance
“…The integrated gRNA sequences were PCR amplified using primers specific to the integrated lentiviral vector sequence and sequenced using the Illumina sequencing technology. Illumina library construction was performed as previously described 47 . Briefly, a total of 96 µg of DNA per sample was split into 24 PCR reactions each with the volume of 100 µl, containing a final concentration of 0.5 µM of each of the following primers (Integrated DNA Technologies, 5644 5 ‘-AATGATACGGCGACCACCGAGATCTACACTCGATTTCTTGGCTTTATATATCTTGTGGAAAGGA-3 ‘ and INDEX 5 ‘-CAAGCAGAAGACGGCATACGAGATXXXXXXXXXXGTGACTGGAGTTCAGACGTGTGCTCTTCCGATC-3 ‘, where the Xs denote a 10 base PCR-sample specific barcode used for data demultiplexing following sequencing).…”
Section: Methodsmentioning
confidence: 99%
See 4 more Smart Citations
“…The integrated gRNA sequences were PCR amplified using primers specific to the integrated lentiviral vector sequence and sequenced using the Illumina sequencing technology. Illumina library construction was performed as previously described 47 . Briefly, a total of 96 µg of DNA per sample was split into 24 PCR reactions each with the volume of 100 µl, containing a final concentration of 0.5 µM of each of the following primers (Integrated DNA Technologies, 5644 5 ‘-AATGATACGGCGACCACCGAGATCTACACTCGATTTCTTGGCTTTATATATCTTGTGGAAAGGA-3 ‘ and INDEX 5 ‘-CAAGCAGAAGACGGCATACGAGATXXXXXXXXXXGTGACTGGAGTTCAGACGTGTGCTCTTCCGATC-3 ‘, where the Xs denote a 10 base PCR-sample specific barcode used for data demultiplexing following sequencing).…”
Section: Methodsmentioning
confidence: 99%
“…Sequencing analysis was performed as previously described 47 . In short, raw sequencing reads were converted to FASTQ format using bcl2fastq2 (version 2.17.1.14, retrieved from http://support.illumina.com/downloads/bcl2fastq-conversion-software-v217.html); trimmed to the guide sequence with the fastx-toolkit (version 0.0.13, retrieved from http://hannonlab.cshl.edu/fastx_toolkit/index.html) and aligned to the sgRNA sequences in the library using bowtie 49 with no mismatches allowed.…”
Section: Methodsmentioning
confidence: 99%
See 3 more Smart Citations